Project Grant R35GM161699
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $429,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective March 6, 2026 through February 28, 2031. The grant funds investigator-initiated research examining the regulation of endoplasmic reticulum-selective autophagy (ER-phagy) during cellular stress conditions. The research...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $390,000 Project Grant award effective August 1, 2025, through June 30, 2030, from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859). This award funds fundamental research investigating tissue-specific regulation of autophagy by proppins (B-propellers that bind phosphoinositides), specifically the WIPI1-WIPI4 protein...
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $335,400 Project Grant award, effective September 1, 2025, through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) to conduct fundamental research on phosphatidylserine (PS) synthesis, trafficking, and its role in cellular cholesterol homeostasis. The research project will be completed by May 31, 2029, and focuses on...
- Federal Grant Award Summary The University of Texas at San Antonio received a $398,444 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. The award funds basic research investigating the modulation of Transient Receptor Potential (TRP) channels by lipids and protein folding helper enzymes. TRP channels are ubiquitously expressed throughout...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 15, 2025, with a completion date of July 31, 2027. This award supports fundamental biomedical research investigating novel mechanisms of purine regulation and their roles in human pathophysiology, specifically...
- Summary of Federal Grant Award The University of Texas Health Science Center at Houston has been awarded $868,584 under the Biomedical Research and Research Training program (CFDA 93.859), administered by the National Institute of General Medical Sciences within the National Institutes of Health. The project grant, effective from September 1, 2025, through August 31, 2027, supports fundamental research investigating how ribonucleic acid (RNA) modifications regulate adaptive messenger RNA...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $2.23 million Project Grant awarded on September 3, 2025, under the National Institute of General Medical Sciences' Biomedical Research and Research Training program (CFDA 93.859). The five-year award (completion date: August 31, 2029) funds fundamental research to elucidate the catalytic mechanisms and regulatory roles of bacterial alarmone hydrolases—specifically enzymes that degrade (ppGpp), a...
- Federal Grant Award Summary The University of Texas at Austin received a $385,671 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. The award supports fundamental research aimed at developing chemical strategies to control the conformational properties of bioactive peptides and proteins. The research will focus on synthesizing...
- Federal Project Grant Award Summary Texas A&M Agrilife Research received a $583,420 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award supports fundamental research to elucidate the role of protein conformational entropy (ΔSconf) in protein structural stability, dynamics, and function. The research employs nuclear magnetic...
- Federal Project Grant Award Summary The University of Texas at Arlington received a $360,188 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award supports fundamental research utilizing chemical proteomics and mass spectrometry-based technologies to investigate inflammatory signaling pathways regulated by pattern recognition...
The University of Texas Health Science Center at Houston received a $390,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 1, 2026, with completion scheduled for December 31, 2030. This research project investigates inter-organelle unfolded protein response (UPR) coordination and cellular proteostasis, specifically examining how cells maintain protein homeostasis under stress conditions relevant to aging. The research focuses on understanding communication and coordination mechanisms between organelle-specific UPRs in mitochondria, the endoplasmic reticulum, and the cytosol, with particular emphasis on the previously underexplored interplay between lipid metabolism and protein-folding processes. The project's central research objective is to elucidate the connection between lipid homeostasis and proteostasis through organelle-to-organelle communication, with a hypothesis that the cardiolipin-to-ceramide lipid ratio is critical for stress response pathway communication across cellular compartments. Preliminary findings from C. elegans and mammalian cell culture systems have demonstrated that mitochondrial UPR can simultaneously activate cytosolic UPR while inhibiting endoplasmic reticulum UPR to enhance cellular resistance to proteotoxic stress. This fundamental research addresses the broader goal of understanding how cells utilize different organelle stress responses to maintain homeostasis, with potential implications for understanding lipid dyshomeostasis in neurodegenerative diseases, cardiovascular disease, diabetes, and cancer.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $390.0k | 2/27/26 |